1National Cancer Control Institute, National Cancer Center, Goyang, Korea.
2Department of Preventive Medicine and Institute of Health Service Research, Yonsei University College of Medicine, Seoul, Korea.
Copyright © 2011 by the Korean Cancer Association
This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Target population | No. of participants | Participation rate (%) | UGI series | Upper endoscopy | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
|
||||||||||
No. of participants | Recall cases (n)a) | Recall rate (%) | 95% CI | No. of participants | Recall cases (n)b) | Recall rate (%) | 95% CI | ||||
Total | 7,132,820 | 2,076,544 | 29.1 | 1,198,061 | 399,336 | 33.3 | 33.3-33.4 | 878,483 | 26,950 | 3.1 | 3.0-3.1 |
Gender | |||||||||||
Male | 3,407,649 | 859,854 | 25.2 | 491,927 | 165,953 | 33.7 | 33.6-33.9 | 367,927 | 14,042 | 3.8 | 3.8-3.9 |
Female | 3,725,171 | 1,216,690 | 32.7 | 706,134 | 233,383 | 33.1 | 32.9-33.2 | 510,556 | 12,908 | 2.5 | 2.5-2.6 |
Health insurance type | |||||||||||
NHI | 6,203,392 | 1,904,983 | 30.7 | 1,076,122 | 361,900 | 33.6 | 33.5-33.7 | 828,861 | 25,361 | 3.1 | 3.0-3.1 |
MAP | 929,428 | 171,561 | 18.5 | 121,939 | 37,436 | 30.7 | 30.4-31.0 | 49,622 | 1,589 | 3.2 | 3.1-3.4 |
Age group (yr) | |||||||||||
40-49 | 2,790,423 | 663,504 | 23.8 | 328,417 | 111,899 | 34.1 | 33.9-34.2 | 335,087 | 8,593 | 2.6 | 2.5-2.6 |
50-59 | 2,066,304 | 658,276 | 31.9 | 359,931 | 126,648 | 35.2 | 35.0-35.3 | 298,345 | 9,060 | 3.0 | 3.0-3.1 |
60-69 | 1,261,597 | 500,649 | 39.7 | 312,443 | 100,042 | 32.0 | 31.9-32.2 | 188,206 | 6,812 | 3.6 | 3.5-3.7 |
≥70 | 1,014,496 | 254,115 | 25.0 | 197,270 | 60,747 | 30.8 | 30.6-31.0 | 56,845 | 2,485 | 4.4 | 4.2-4.5 |
Residence area | |||||||||||
Seoul | 1,290,766 | 332,469 | 25.8 | 165,412 | 41,400 | 25.0 | 24.8-25.2 | 167,057 | 6,424 | 3.8 | 3.8-3.9 |
Busan | 581,295 | 179,491 | 30.9 | 107,545 | 27,985 | 26.0 | 25.8-26.3 | 71,946 | 1,550 | 2.2 | 2.1-2.3 |
Daegu | 371,550 | 15,289 | 31.0 | 57,205 | 19,891 | 34.8 | 34.4-35.2 | 58,084 | 1,102 | 1.9 | 1.8-2.0 |
Daejeon | 183,722 | 62,213 | 33.9 | 35,531 | 13,636 | 38.4 | 37.9-38.9 | 26,682 | 614 | 2.3 | 2.1-2.5 |
Incheon | 398,470 | 92,676 | 23.3 | 48,653 | 11,435 | 23.5 | 23.1-23.9 | 44,023 | 3,256 | 7.4 | 7.2-7.6 |
Gwangju | 185,229 | 51,920 | 28.0 | 25,538 | 5,985 | 23.4 | 22.9-24.0 | 26,382 | 783 | 3.0 | 2.8-3.2 |
Ulsan | 121,576 | 30,615 | 25.2 | 17,102 | 4,570 | 26.7 | 26.1-27.4 | 13,513 | 239 | 1.8 | 1.6-2.0 |
Gyeonggi | 1,438,321 | 377,274 | 26.2 | 171,441 | 56,164 | 32.8 | 32.5-33.0 | 205,833 | 5,643 | 2.7 | 2.7-2.8 |
Gangwon | 259,406 | 86,326 | 33.3 | 68,227 | 33,896 | 49.7 | 49.3-50.1 | 18,099 | 457 | 2.5 | 2.3-2.8 |
Chungcheongbuk | 245,687 | 85,784 | 34.9 | 63,497 | 23,699 | 37.3 | 37.0-37.7 | 22,287 | 772 | 3.5 | 3.2-3.7 |
Chungcheongnam | 329,716 | 105,577 | 32.0 | 71,759 | 22,504 | 31.4 | 31.0-31.7 | 33,818 | 476 | 1.4 | 1.3-1.5 |
Jeollabuk | 328,079 | 108,692 | 33.1 | 74,807 | 23,922 | 32.0 | 31.6-32.3 | 33,885 | 998 | 2.9 | 2.8-3.1 |
Jeollanam | 363,882 | 122,251 | 33.6 | 75,693 | 20,330 | 26.9 | 26.5-27.2 | 46,558 | 1,486 | 3.2 | 3.0-3.4 |
Gyeongsangbuk | 459,180 | 150,775 | 32.8 | 96,816 | 48,051 | 49.6 | 49.3-50.0 | 53,959 | 1,627 | 3.0 | 2.9-3.2 |
Gyeongsangnam | 488,203 | 151,009 | 30.9 | 100,927 | 40,615 | 40.2 | 39.9-40.5 | 50,082 | 1,006 | 2.0 | 1.9-2.1 |
Jeju | 87,738 | 24,183 | 27.6 | 17,908 | 5,253 | 29.3 | 28.7-30.0 | 6,275 | 517 | 8.2 | 7.6-8.9 |
UGI, upper gastrointestinal; CI, confidence interval; NHI, National Health Insurance; MAP, Medical Aid Program. a)Participants who received 'needing further evaluation,' 'suspicious of cancer,' or 'gastric cancer' or received additional upper endoscopy for further evaluation after undergoing UGI series were deemed to be recall cases, b)Participants who received 'needing further evaluation,' 'suspicious of cancer,' or 'gastric cancer' were deemed to be recall cases.
Target population | No. of participants | Participation rate (%) | UGI series | Upper endoscopy | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|
No. of participants | Recall cases (n) |
Recall rate (%) | 95% CI | No. of participants | Recall cases (n) |
Recall rate (%) | 95% CI | ||||
Total | 7,132,820 | 2,076,544 | 29.1 | 1,198,061 | 399,336 | 33.3 | 33.3-33.4 | 878,483 | 26,950 | 3.1 | 3.0-3.1 |
Gender | |||||||||||
Male | 3,407,649 | 859,854 | 25.2 | 491,927 | 165,953 | 33.7 | 33.6-33.9 | 367,927 | 14,042 | 3.8 | 3.8-3.9 |
Female | 3,725,171 | 1,216,690 | 32.7 | 706,134 | 233,383 | 33.1 | 32.9-33.2 | 510,556 | 12,908 | 2.5 | 2.5-2.6 |
Health insurance type | |||||||||||
NHI | 6,203,392 | 1,904,983 | 30.7 | 1,076,122 | 361,900 | 33.6 | 33.5-33.7 | 828,861 | 25,361 | 3.1 | 3.0-3.1 |
MAP | 929,428 | 171,561 | 18.5 | 121,939 | 37,436 | 30.7 | 30.4-31.0 | 49,622 | 1,589 | 3.2 | 3.1-3.4 |
Age group (yr) | |||||||||||
40-49 | 2,790,423 | 663,504 | 23.8 | 328,417 | 111,899 | 34.1 | 33.9-34.2 | 335,087 | 8,593 | 2.6 | 2.5-2.6 |
50-59 | 2,066,304 | 658,276 | 31.9 | 359,931 | 126,648 | 35.2 | 35.0-35.3 | 298,345 | 9,060 | 3.0 | 3.0-3.1 |
60-69 | 1,261,597 | 500,649 | 39.7 | 312,443 | 100,042 | 32.0 | 31.9-32.2 | 188,206 | 6,812 | 3.6 | 3.5-3.7 |
≥70 | 1,014,496 | 254,115 | 25.0 | 197,270 | 60,747 | 30.8 | 30.6-31.0 | 56,845 | 2,485 | 4.4 | 4.2-4.5 |
Residence area | |||||||||||
Seoul | 1,290,766 | 332,469 | 25.8 | 165,412 | 41,400 | 25.0 | 24.8-25.2 | 167,057 | 6,424 | 3.8 | 3.8-3.9 |
Busan | 581,295 | 179,491 | 30.9 | 107,545 | 27,985 | 26.0 | 25.8-26.3 | 71,946 | 1,550 | 2.2 | 2.1-2.3 |
Daegu | 371,550 | 15,289 | 31.0 | 57,205 | 19,891 | 34.8 | 34.4-35.2 | 58,084 | 1,102 | 1.9 | 1.8-2.0 |
Daejeon | 183,722 | 62,213 | 33.9 | 35,531 | 13,636 | 38.4 | 37.9-38.9 | 26,682 | 614 | 2.3 | 2.1-2.5 |
Incheon | 398,470 | 92,676 | 23.3 | 48,653 | 11,435 | 23.5 | 23.1-23.9 | 44,023 | 3,256 | 7.4 | 7.2-7.6 |
Gwangju | 185,229 | 51,920 | 28.0 | 25,538 | 5,985 | 23.4 | 22.9-24.0 | 26,382 | 783 | 3.0 | 2.8-3.2 |
Ulsan | 121,576 | 30,615 | 25.2 | 17,102 | 4,570 | 26.7 | 26.1-27.4 | 13,513 | 239 | 1.8 | 1.6-2.0 |
Gyeonggi | 1,438,321 | 377,274 | 26.2 | 171,441 | 56,164 | 32.8 | 32.5-33.0 | 205,833 | 5,643 | 2.7 | 2.7-2.8 |
Gangwon | 259,406 | 86,326 | 33.3 | 68,227 | 33,896 | 49.7 | 49.3-50.1 | 18,099 | 457 | 2.5 | 2.3-2.8 |
Chungcheongbuk | 245,687 | 85,784 | 34.9 | 63,497 | 23,699 | 37.3 | 37.0-37.7 | 22,287 | 772 | 3.5 | 3.2-3.7 |
Chungcheongnam | 329,716 | 105,577 | 32.0 | 71,759 | 22,504 | 31.4 | 31.0-31.7 | 33,818 | 476 | 1.4 | 1.3-1.5 |
Jeollabuk | 328,079 | 108,692 | 33.1 | 74,807 | 23,922 | 32.0 | 31.6-32.3 | 33,885 | 998 | 2.9 | 2.8-3.1 |
Jeollanam | 363,882 | 122,251 | 33.6 | 75,693 | 20,330 | 26.9 | 26.5-27.2 | 46,558 | 1,486 | 3.2 | 3.0-3.4 |
Gyeongsangbuk | 459,180 | 150,775 | 32.8 | 96,816 | 48,051 | 49.6 | 49.3-50.0 | 53,959 | 1,627 | 3.0 | 2.9-3.2 |
Gyeongsangnam | 488,203 | 151,009 | 30.9 | 100,927 | 40,615 | 40.2 | 39.9-40.5 | 50,082 | 1,006 | 2.0 | 1.9-2.1 |
Jeju | 87,738 | 24,183 | 27.6 | 17,908 | 5,253 | 29.3 | 28.7-30.0 | 6,275 | 517 | 8.2 | 7.6-8.9 |
UGI, upper gastrointestinal; CI, confidence interval; NHI, National Health Insurance; MAP, Medical Aid Program. a)Participants who received 'needing further evaluation,' 'suspicious of cancer,' or 'gastric cancer' or received additional upper endoscopy for further evaluation after undergoing UGI series were deemed to be recall cases, b)Participants who received 'needing further evaluation,' 'suspicious of cancer,' or 'gastric cancer' were deemed to be recall cases.